Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Insulin Degludec on Risk of Symptomatic Nocturnal Hypoglycaemia in Subjects With Type 1 Diabetes and High Risk of Nocturnal Severe Hypoglycaemia

NCT02192450 is registered in ClinicalTrials.gov with Nordsjaellands Hospital as lead sponsor.

NCT NCT02192450
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02192450 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Insulin Degludec on Risk of Symptomatic Nocturnal Hypoglycaemia in Subjects With Type 1 Diabetes and High Risk of Nocturnal Severe Hypoglycaemia
Lead sponsor
Nordsjaellands Hospital
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2015
Completion date
February 28, 2019
Enrollment
149 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nocturnal hypoglycemia, recurrent severe hypoglycaemia, type 1 diabetes mellitus